
Our core focus
Our core focus is to represent the views of the off-patent industry to increase understanding and awareness of the important role of generic and biosimilar medicines to the NHS and patients. The UK off-patent market is a success story, delivering critical savings and increasing patient access. It is vital that the operating environment is maintained and that government policy is supportive and encouraging. We want to foster a sustainable market in the UK which continues to deliver for patients and payors alike.
